pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
  1. pharmadog
  2. ›calendar
  3. ›device recall
device recall
save

Tandem Diabetes Care, Inc. device recall (Cls II)

January 30, 2026$TNDMupdated 5mo ago
community read0 votes

Tandem pumps are battery-operated infusion pumps capable of both basal and bolus delivery of insulin. The pumps utilize a motor-driven mechanism to deliver insulin from within a disposable cartridge, through an infusion set, into a patient s subcutaneous tissue. As with current insulin infusion pumps on the U.S. market, the desired timing and quantity of the insulin delivery is programmed by the user (i.e., the patient). — Reason: The Czech language user guide contained multiple translation errors. The most significant error was that it incorrectly instructs users to verify that the infusion set is connected to the body, when it should instead direct users to confirm that the infusion set is not connected to the body. Following this instruction could result in unintended insulin delivery, potentially leading to a hypoglycemic event. — Status: Ongoing

view source ↗
Data sources
fda device recalls
last refreshed 5mo ago
Found something off?
🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

same company · ±60 days · 6

  • device adverse eventFREESTYLE LIBRE 3 PLUS — Injury eventMar 31, 2026
  • device adverse eventFREESTYLE LIBRE 2 PLUS — Injury eventMar 31, 2026
  • device adverse eventT:SLIM X2 INSULIN PUMP WITH CONTROL-IQ TECHNOLOGY — Injury eventMar 31, 2026
  • device adverse eventTANDEM MOBI INSULIN PUMP WITH CONTROL-IQ+ TECHNOLOGY — Injury eventMar 31, 2026
  • device adverse eventT:SLIM X2 INSULIN PUMP WITH CONTROL-IQ TECHNOLOGY — Injury eventMar 31, 2026
  • device adverse eventFREESTYLE LIBRE 2 PLUS — Injury eventMar 31, 2026

🐶 often sniffed alongside

top 5
  • druginsulin21 co-mentions · 7 sources
  • tagType 2 Diabetes10 co-mentions · 10 sources
  • tagAdCom5 co-mentions · 5 sources
  • tag510(k) Clearance5 co-mentions · 5 sources
  • tagRecall5 co-mentions · 5 sources

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?